MedPage Today on MSN
Controversial CDC-Funded Hep B Study Halted
A controversial study on hepatitis B vaccination in Guinea-Bissau that was funded in part by the U.S. CDC has been halted.
Hepatitis B is a virus that can damage the liver and lead to lifelong health problems. The hepatitis B vaccine prevents short ...
The federal Centers for Disease Control and Prevention (CDC) has announced a major update to the childhood vaccine schedule, ...
A new 10-year regional study reveals that adults living with both HIV and hepatitis B virus across the Asia-Pacific face ...
A federal panel decided to delay the birth dose of hepatitis b vaccine unless there is maternal hepatitis b blood test ...
Opinion
My grandfather created the hepatitis B vaccine. Would he recognize public health in the U.S. today?
Physician Emilie G.C. Thompson’s grandfather created the hepatitis B vaccine. Now she’s watching his legacy get dismantled.
"If you’ve been hearing renewed debate about the hepatitis B vaccine for newborns, you’re not alone. A mix of policy proposals, selective research ...
The Tuskegee syphilis study stands as one of the greatest moral failures in American medical history, a reminder of what ...
If something as fundamental as newborn vaccination schedule can be revised, it raises an important question: Is the science ...
GSK’s potential “functional cure” for hepatitis B drug has proven its worth in a pair of hotly anticipated phase 3 studies, setting up the pharma for a push to the FDA.
The CDC's move follows a vote from Health Secretary Robert F. Kennedy Jr.'s vaccine advisory panel that entails a major ...
The CHB therapeutics market offers growth opportunities via emerging functional cures like bepirovirsen and selgantolimod, amidst challenges from patent expiries and generic erosion. Strategic R&D, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback